ICD-10 Code C83.59
Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites
“Lymphoblastic lymphoma, extrnod and solid organ sites” for short
C83.59 is the medical classification code used for lymphoblastic diffuse lymphoma that manifests in extranodal and solid organ sites. This condition represents a highly aggressive, rapidly progressive subtype of non-Hodgkin lymphoma derived from precursor T-cell or precursor B-cell lymphoblasts located outside the primary lymphatic structures such as the lymph nodes, spleen, or tonsils. Clinically, patients with extranodal involvement may present with solid tumors affecting organs such as the anterior mediastinum, central nervous system, skin, bones, liver, or gastrointestinal tract, often leading to rapid symptom onset due to mass effect. Lymphoblastic lymphoma is pathologically and immunophenotypically closely related to acute lymphoblastic leukemia, but it is classified as a lymphoma when bone marrow involvement remains below twenty-five percent blast infiltration. Related diseases and conditions associated with this code include precursor T-cell lymphoblastic lymphoma, precursor B-cell lymphoblastic lymphoma, acute lymphoblastic leukemia, diffuse non-follicular lymphoma, mediastinal mass syndrome, and secondary extranodal involvement from precursor cell hematologic malignancies.
C83.59 is a valid billable ICD-10 diagnosis code for Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.
See also, ICD-10 Table of Neoplasms.
- MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Lymphoma and Leukemia with Major Procedure - MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Lymphoma and Non-Acute Leukemia with Other Procedure - MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Lymphoma and Non-Acute Leukemia
ICD-10 code C83.59 is based on the following Tabular structure:
Chapter 2: Neoplasms- Section C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Category C83: Non-follicular lymphoma
↑ Parent code:
C83.5 for Lymphoblastic (diffuse) lymphoma
Should you use C83.59 or C8359 (with or without decimal point) when submitting claims?
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you
but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.
This note further define, or give examples of, the content of the code or category.
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.
A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.